These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26024927)

  • 1. Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.
    Igarashi M; DiPatrizio NV; Narayanaswami V; Piomelli D
    Biochim Biophys Acta; 2015 Sep; 1851(9):1218-26. PubMed ID: 26024927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipid messenger OEA links dietary fat intake to satiety.
    Schwartz GJ; Fu J; Astarita G; Li X; Gaetani S; Campolongo P; Cuomo V; Piomelli D
    Cell Metab; 2008 Oct; 8(4):281-288. PubMed ID: 18840358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors.
    Duca FA; Swartz TD; Sakar Y; Covasa M
    Int J Obes (Lond); 2013 Mar; 37(3):375-81. PubMed ID: 22546775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.
    Igarashi M; Narayanaswami V; Kimonis V; Galassetti PM; Oveisi F; Jung KM; Piomelli D
    Pharmacol Res; 2017 Mar; 117():75-81. PubMed ID: 28007570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
    Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.
    Fu J; Astarita G; Gaetani S; Kim J; Cravatt BF; Mackie K; Piomelli D
    J Biol Chem; 2007 Jan; 282(2):1518-28. PubMed ID: 17121838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.
    Sihag J; Jones PJH
    Obes Rev; 2018 Feb; 19(2):178-197. PubMed ID: 29124885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
    Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
    Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine.
    Fu J; Dipatrizio NV; Guijarro A; Schwartz GJ; Li X; Gaetani S; Astarita G; Piomelli D
    J Neurosci; 2011 Apr; 31(15):5730-6. PubMed ID: 21490214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid.
    Igarashi M; Iwasa K; Yoshikawa K
    Prostaglandins Leukot Essent Fatty Acids; 2021 Feb; 165():102228. PubMed ID: 33385936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.
    Guijarro A; Fu J; Astarita G; Piomelli D
    Pharmacol Res; 2010 Jan; 61(1):27-33. PubMed ID: 19778614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced obese and diet-resistant rats.
    Hyland NP; Pittman QJ; Sharkey KA
    Peptides; 2007 Jun; 28(6):1185-90. PubMed ID: 17475366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet-induced obese rats.
    Cluny NL; Eller LK; Keenan CM; Reimer RA; Sharkey KA
    Obesity (Silver Spring); 2015 Apr; 23(4):769-78. PubMed ID: 25820256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.
    Rahardjo GL; Huang XF; Tan YY; Deng C
    Endocrinology; 2007 Oct; 148(10):4704-10. PubMed ID: 17615145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary oleic acid contributes to the regulation of food intake through the synthesis of intestinal oleoylethanolamide.
    Igarashi M; Iwasa K; Hayakawa T; Tsuduki T; Kimura I; Maruyama K; Yoshikawa K
    Front Endocrinol (Lausanne); 2022; 13():1056116. PubMed ID: 36733808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oleoylethanolamide as a feeding regulator in goldfish.
    Tinoco AB; Armirotti A; Isorna E; Delgado MJ; Piomelli D; de Pedro N
    J Exp Biol; 2014 Aug; 217(Pt 15):2761-9. PubMed ID: 24855680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.